Farallon Capital Management 13F holdings, Q1 2019
Holdings as of March 31, 2019 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 93 US equity positions worth $12.1bn in its Q1 2019 13F filing. The largest position was ALTABA INC at 16.9% of the reported book, followed by CELG and RED HAT INC. Against the Q4 2018 filing, it opened 8 new positions, added to 17 and reduced 19 among the top 50 holdings.
What did Farallon Capital Management own in Q1 2019? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2018 |
|---|---|---|---|---|---|---|---|
| 1 | ALTABA INC | 16.9% | $2.0bn | 27,607,317 | 0% | held | |
| 2 | CELG CELGENE CORP | 6.6% | $795.3m | 8,430,000 | – | new | |
| 3 | RED HAT INC | 5.0% | $608.3m | 3,329,749 | 24% | added | |
| 4 | WAB WABTEC CORP | Industrials | 3.8% | $460.2m | 6,242,572 | 13% | added |
| 5 | GOOG ALPHABET INC | Communication Services | 2.8% | $343.0m | 292,328 | -37% | reduced |
| 6 | IHS MARKIT LTD | 2.7% | $332.1m | 6,107,546 | 3% | added | |
| 7 | BKNG BOOKING HLDGS INC | Consumer Cyclical | 2.7% | $322.8m | 184,982 | 12% | added |
| 8 | IQV IQVIA HLDGS INC | Healthcare | 2.6% | $310.4m | 2,157,595 | -33% | reduced |
| 9 | META FACEBOOK INC | Communication Services | 2.5% | $304.9m | 1,829,173 | -40% | reduced |
| 10 | TRU TRANSUNION | Financial Services | 2.4% | $288.6m | 4,317,846 | -18% | reduced |
| 11 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 2.3% | $279.9m | 806,938 | -25% | reduced |
| 12 | V VISA INC | Financial Services | 2.1% | $251.6m | 1,610,679 | -31% | reduced |
| 13 | FIS FIDELITY NATL INFORMATION SV | Technology | 2.0% | $240.3m | 2,124,515 | 12% | added |
| 14 | ELV ANTHEM INC | Healthcare | 2.0% | $236.8m | 825,000 | -21% | reduced |
| 15 | PLAYA HOTELS & RESORTS NV | 1.9% | $233.5m | 30,606,930 | 0% | held | |
| 16 | EFX EQUIFAX INC | Industrials | 1.9% | $232.1m | 1,959,018 | -9% | reduced |
| 17 | CITRIX SYS INC | 1.6% | $198.3m | 1,990,184 | 36% | added | |
| 18 | MSFT MICROSOFT CORP | Technology | 1.6% | $192.3m | 1,630,401 | -37% | reduced |
| 19 | SPGI S&P GLOBAL INC | Financial Services | 1.6% | $191.9m | 911,551 | – | new |
| 20 | EQIX EQUINIX INC | Real Estate | 1.6% | $188.9m | 416,759 | -62% | reduced |
| 21 | GD GENERAL DYNAMICS CORP | Industrials | 1.5% | $183.1m | 1,081,488 | -34% | reduced |
| 22 | ASND ASCENDIS PHARMA A S | Healthcare | 1.5% | $176.6m | 1,500,000 | 0% | held |
| 23 | SHW SHERWIN WILLIAMS CO | Basic Materials | 1.4% | $165.5m | 384,163 | – | new |
| 24 | SE SEA LTD | Consumer Cyclical | 1.3% | $162.8m | 6,920,000 | – | new |
| 25 | AZN ASTRAZENECA PLC | Healthcare | 1.3% | $157.1m | 3,885,000 | 0% | held |
| 26 | CI CIGNA CORP NEW | Healthcare | 1.3% | $152.0m | 945,000 | -10% | reduced |
| 27 | WELLCARE HEALTH PLANS INC | 1.2% | $151.1m | 560,000 | – | new | |
| 28 | GOLDCORP INC NEW | 1.2% | $148.3m | 12,960,000 | – | new | |
| 29 | ARRAY BIOPHARMA INC | 1.1% | $134.1m | 5,500,000 | -4% | reduced | |
| 30 | ARRIS INTERNATIONAL PLC | 1.0% | $118.4m | 3,745,000 | 5% | added | |
| 31 | ZOGENIX INC | 0.9% | $112.8m | 2,050,500 | 0% | held | |
| 32 | XLRN ACCELERON PHARMA INC | 0.9% | $110.6m | 2,375,000 | 13% | added | |
| 33 | LIBERTY GLOBAL PLC | 0.9% | $104.3m | 4,308,106 | -13% | reduced | |
| 34 | MYOKARDIA INC | 0.8% | $101.4m | 1,950,278 | 22% | added | |
| 35 | FOX FOX CORP | Communication Services | 0.8% | $100.7m | 2,807,431 | – | new |
| 36 | LIBERTY GLOBAL PLC | 0.8% | $98.4m | 3,949,553 | -34% | reduced | |
| 37 | SG7 SAGE THERAPEUTICS INC | 0.8% | $95.4m | 600,000 | 50% | added | |
| 38 | SPARK THERAPEUTICS INC | 0.8% | $93.4m | 820,000 | – | new | |
| 39 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.7% | $89.8m | 940,000 | 2% | added |
| 40 | MIRATI THERAPEUTICS INC | 0.7% | $88.0m | 1,200,000 | -8% | reduced | |
| 41 | GLOBAL BLOOD THERAPEUTICS IN | 0.7% | $79.4m | 1,500,000 | 3% | added | |
| 42 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.6% | $77.5m | 650,000 | 2% | added |
| 43 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 0.6% | $75.7m | 415,000 | -60% | reduced |
| 44 | EXEL EXELIXIS INC | Healthcare | 0.6% | $71.4m | 3,000,000 | 50% | added |
| 45 | AMARIN CORP PLC | 0.6% | $67.5m | 3,250,000 | -7% | reduced | |
| 46 | REATA PHARMACEUTICALS INC | 0.5% | $64.1m | 750,000 | 7% | added | |
| 47 | GRFS GRIFOLS S A | Healthcare | 0.5% | $58.8m | 2,926,352 | 23% | added |
| 48 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 0.5% | $54.4m | 5,725,000 | 0% | held |
| 49 | NVCR NOVOCURE LTD | Healthcare | 0.4% | $50.6m | 1,050,000 | -16% | reduced |
| 50 | FIBROGEN INC | 0.4% | $49.8m | 915,579 | 22% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.